Table 2.

Effect of the COVID-19 pandemic on the number of new antiretroviral therapy initiation and viral load testing in five countries contributing to the IeDEA pediatric West African database to evaluate AIDS, Poisson segmented regression models.

	Level change before the COVID-19 pandemic declaration			Trend change during COVID-19 pandemic
	IRR*	95% CI**	p-value	IRR	95% CI	p-value
Antiretroviral therapy initiation
Benin	1.232	0.746–2.037	0.431	0.954	0.901–1.009	0.126
Burkina Faso	0.162	0.043–0.609	0.019	1.010	0.916–1.113	0.852
Côte d’Ivoire	0.825	0.629–1.082	0.190	1.062	1.032–1.093	0.001
Ghana	0.291	0.171–0.494	0.001	1.146	1.073–1.224	0.002
Mali	1.346	0.734–2.469	0.355	0.958	0.906–1.012	0.154
Viral load testing
Benin	0.714	0.246–2.073	0.548	1.048	0.936–1.174	0.433
Burkina Faso	0.409	0.253–0.662	0.003	1.020	0.957–1.088	0.550
Côte d’ivoire	1.058	0.765–1.463	0.739	0.954	0.922–0.987	0.018
Ghana	2.108	0.951–4.671	0.091	0.776	0.693–0.870	0.001
Mali	2.655	1.207–5.836	0.032	0.949	0.897–1.005	0.097

*Incidence rate ratio; **95% confidence intervals. Bold p-values indicate statistical significance (p < 0.05).